418 related articles for article (PubMed ID: 21151138)
1. Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome.
Clement LC; Avila-Casado C; Macé C; Soria E; Bakker WW; Kersten S; Chugh SS
Nat Med; 2011 Jan; 17(1):117-22. PubMed ID: 21151138
[TBL] [Abstract][Full Text] [Related]
2. [ManNAc, a new therapeutic agent to reduce Angptl4-induced proteinuria in MCD].
Clément L; Macé C
Med Sci (Paris); 2016; 32(6-7):606-11. PubMed ID: 27406771
[TBL] [Abstract][Full Text] [Related]
3. New insights into human minimal change disease: lessons from animal models.
Chugh SS; Clement LC; Macé C
Am J Kidney Dis; 2012 Feb; 59(2):284-92. PubMed ID: 21974967
[TBL] [Abstract][Full Text] [Related]
4. "Idiopathic" minimal change nephrotic syndrome: a podocyte mystery nears the end.
Chugh SS; Clement LC
Am J Physiol Renal Physiol; 2023 Dec; 325(6):F685-F694. PubMed ID: 37795536
[TBL] [Abstract][Full Text] [Related]
5. Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome.
Clement LC; Macé C; Avila-Casado C; Joles JA; Kersten S; Chugh SS
Nat Med; 2014 Jan; 20(1):37-46. PubMed ID: 24317117
[TBL] [Abstract][Full Text] [Related]
6. Angiopoietin-like-4 and minimal change disease.
Cara-Fuentes G; Segarra A; Silva-Sanchez C; Wang H; Lanaspa MA; Johnson RJ; Garin EH
PLoS One; 2017; 12(4):e0176198. PubMed ID: 28441404
[TBL] [Abstract][Full Text] [Related]
7. Calcineurin inhibitors ameliorate PAN-induced podocyte injury through the NFAT-Angptl4 pathway.
Shen X; Zhang Y; Lin C; Weng C; Wang Y; Feng S; Wang C; Shao X; Lin W; Li B; Wang H; Chen J; Jiang H
J Pathol; 2020 Nov; 252(3):227-238. PubMed ID: 32686149
[TBL] [Abstract][Full Text] [Related]
8. Angiopoietin-Like-4, a Potential Target of Tacrolimus, Predicts Earlier Podocyte Injury in Minimal Change Disease.
Li JS; Chen X; Peng L; Wei SY; Zhao SL; Diao TT; He YX; Liu F; Wei QJ; Zhang QF; Li B
PLoS One; 2015; 10(9):e0137049. PubMed ID: 26352670
[TBL] [Abstract][Full Text] [Related]
9. The calcineurin inhibitor tacrolimus reduces proteinuria in membranous nephropathy accompanied by a decrease in angiopoietin-like-4.
Peng L; Ma J; Cui R; Chen X; Wei SY; Wei QJ; Li B
PLoS One; 2014; 9(8):e106164. PubMed ID: 25165975
[TBL] [Abstract][Full Text] [Related]
10. ANGPTL4 promotes nephrotic syndrome by downregulating podocyte expression of ACTN4 and podocin.
Li Y; Xu Z; Deng H; Liu M; Lin X; Zhang M; Li G; Yue S; Gao X
Biochem Biophys Res Commun; 2023 Jan; 639():176-182. PubMed ID: 36495766
[TBL] [Abstract][Full Text] [Related]
11. Nephrotic syndrome: components, connections, and angiopoietin-like 4-related therapeutics.
Macé C; Chugh SS
J Am Soc Nephrol; 2014 Nov; 25(11):2393-8. PubMed ID: 24854282
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of podocyte-secreted angiopoietin-like-4 in diabetic nephropathy.
Ma J; Chen X; Li JS; Peng L; Wei SY; Zhao SL; Li T; Zhu D; He YX; Wei QJ; Li B
Endocrine; 2015 Jun; 49(2):373-84. PubMed ID: 25424436
[TBL] [Abstract][Full Text] [Related]
13. Angiopoietin-like 4 based therapeutics for proteinuria and kidney disease.
Chugh SS; Macé C; Clement LC; Del Nogal Avila M; Marshall CB
Front Pharmacol; 2014; 5():23. PubMed ID: 24611049
[TBL] [Abstract][Full Text] [Related]
14. The proteinuria-hypertriglyceridemia connection as a basis for novel therapeutics for nephrotic syndrome.
Clement LC; Macé C; Del Nogal Avila M; Marshall CB; Chugh SS
Transl Res; 2015 Apr; 165(4):499-504. PubMed ID: 25005737
[TBL] [Abstract][Full Text] [Related]
15. Hyposialylated angiopoietin-like-4 induces apoptosis of podocytes via β1 Integrin/FAK signaling in diabetic nephropathy.
Guo K; Pan P; Wu M; Ma Y; Lu J; Chen H
Mol Cell Endocrinol; 2020 Apr; 505():110730. PubMed ID: 31981598
[TBL] [Abstract][Full Text] [Related]
16. Filtering new facts about kidney disease.
Reiser J
Nat Med; 2011 Jan; 17(1):44-5. PubMed ID: 21217681
[No Abstract] [Full Text] [Related]
17. Proteinuria precedes podocyte abnormalities inLamb2-/- mice, implicating the glomerular basement membrane as an albumin barrier.
Jarad G; Cunningham J; Shaw AS; Miner JH
J Clin Invest; 2006 Aug; 116(8):2272-9. PubMed ID: 16886065
[TBL] [Abstract][Full Text] [Related]
18. Podocyte-Specific Sialylation-Deficient Mice Serve as a Model for Human FSGS.
Niculovic KM; Blume L; Wedekind H; Kats E; Albers I; Groos S; Abeln M; Schmitz J; Beuke E; Bräsen JH; Melk A; Schiffer M; Weinhold B; Münster-Kühnel AK
J Am Soc Nephrol; 2019 Jun; 30(6):1021-1035. PubMed ID: 31040189
[TBL] [Abstract][Full Text] [Related]
19. Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose factor) is a direct glucocorticoid receptor target and participates in glucocorticoid-regulated triglyceride metabolism.
Koliwad SK; Kuo T; Shipp LE; Gray NE; Backhed F; So AY; Farese RV; Wang JC
J Biol Chem; 2009 Sep; 284(38):25593-601. PubMed ID: 19628874
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of Angiopoietin-like-4 Associated with Hyperlipidemia-induced Renal Injury by AMPK/ACC Pathway.
Qiu W; Huang L; Li Y; Liu Q; Lv Y
Curr Pharm Des; 2023; 29(4):300-309. PubMed ID: 36537603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
